Split-image illustration contrasting swift private clinic access to Mounjaro for the wealthy versus long NHS queues for obesity patients in the UK.
AI 生成的图像

UK researchers warn NHS rollout of Mounjaro could widen inequalities in obesity care

由 AI 报道 AI 生成的图像 事实核查

UK specialists say strict early access rules for the weight-loss drug tirzepatide (Mounjaro) risk creating a “two-tier” obesity treatment system, with people who can pay privately getting faster access than those relying on the National Health Service.

A Cl0p ransomware attack has affected patient and staff data at Barts Health NHS. The breach occurred through the organization's Oracle E-Business Suite. Details emerged in a recent report on the incident.

此网站使用 cookie

我们使用 cookie 进行分析以改进我们的网站。阅读我们的 隐私政策 以获取更多信息。
拒绝